Skip to main navigation Skip to search Skip to main content

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

  • Zeynep Irem Ozay
  • , Yeonjung Jo
  • , Georges Gebrael
  • , Micah Ostrowski
  • , Vinay Mathew Thomas
  • , Haoran Li
  • , Ryon P. Graf
  • , Soumyajit Roy
  • , Benjamin L. Maughan
  • , Avirup Guha
  • , Irbaz Bin Riaz
  • , Emmanuel S. Antonarakis
  • , Rana R. McKay
  • , Neeraj Agarwal
  • , Umang Swami

Research output: Contribution to journal › Article › peer-review

Abstract

This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.

Original languageEnglish (US)
Article numbere2620084
JournalJAMA Network Open
Volume9
Issue number6
DOIs
StatePublished - Jun 24 2026

Bibliographical note

Publisher Copyright:
© 2026 Ozay ZI et al.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.

Cite this